IL4 and asthma: Other biologic agents targeting IL-5, and IL-4/IL-13 did not demonstrate any serious or severe treatment-related adverse events in asthma patients, There has been some conflicting information on the safety of TNF-alpha blocking agents in the treatment of asthma.